1H-Indole-3-carbonitrile, 7-[[4-[2-(4-fluorophenyl)ethyl]-1-piperazinyl]carbonyl]- – (443144-26-1)

Pruvanserin, 443144-26-1, 1H-Indole-3-carbonitrile, 7-[[4-[2-(4-fluorophenyl)ethyl]-1-piperazinyl]carbonyl]-, EMD-390920, LSN2422347, UL09X1D9EM, LY2420586, CHEMBL1215661, LY-2422347 FREE BASE, EMD390920, EMD 390920, LSN-2422347, LY2422347, LY-2420586, LY-2422347, EMD-281014, 7-(4-(4-Fluorophenethyl)piperazine-1-carbonyl)-1H-indole-3-carbonitrile, 7-[4-[2-(4-fluorophenyl)ethyl]piperazine-1-carbonyl]-1H-indole-3-carbonitrile, Pruvanserin [INN], Pruvanserin [USAN:INN], UNII-UL09X1D9EM, Pruvanserina, Pruvanserine, 1-((3-Cyano-1H-indol-7-yl)carbonyl)-4-(2-(4-fluorophenyl)ethyl)piperazine, 1-[(3-Cyano-1H-indol-7-yl)carbonyl]-4-[2-(4-fluorophenyl)ethyl]piperazine, 7-{4-(2-(4-Fluorophenyl)ethyl)piperazine-1-carbonyl}-1H-indole-3-carbonitrile, Pruvanserin (USAN/INN), PRUVANSERIN [USAN], SCHEMBL678751, DTXSID40196133, AQRLDDAFYYAIJP-UHFFFAOYSA-N, CHEBI:177485, GLXC-25447, BDBM50324540, DB13094, SB16534, NCGC00370956-01, AS-84847, HY-106246, CS-0025413, NS00072775, D06632, F88776, L001679, Q7253203, BRD-K43837174-003-01-3, (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone, 7-[4-[2-(4-luorophenyl)ethyl]piperazine-1-carbonyl]-1H-indole-3-carbonitrile, 7-{4-[2-(4-fluorophenyl)ethyl]piperazin-1-carbonyl}-1H-indole-3-carbonitrile, Piperazine, 1-((3-cyano-1H-indol-7-yl)carbonyl)-4-(2-(4-fluorophenyl)ethyl)-